AI Governance: A Key Quality Trend for Autumn 2026

As the use of AI continues to expand across GxP-regulated environments, a major trend emerging this autumn is the shift in regulatory focus from "Can we use AI?" to "Can we demonstrate control, traceability, and validation?" Regulators increasingly expect organizations to treat AI governance as an integral part of their Quality Management System (QMS), making it a strategic priority for Quality Assurance teams.

This means that QA professionals are taking a leading role in ensuring that AI-driven processes are properly governed, documented, risk assessed, and supported by appropriate human oversight. Concepts such as AI governance, data integrity, risk-based validation, and Human-in-the-Loop (HITL) controls are rapidly becoming essential components of modern quality systems.

What should companies focus on now?

• Conduct a comprehensive inventory of AI solutions currently in use.
• Integrate AI governance frameworks into the QMS.
• Ensure documented risk assessments and clear evidence of intended use.
• Train QA, Regulatory Affairs, and business functions on evolving regulatory expectations.

Organizations that proactively address AI governance will be better positioned to accelerate innovation while maintaining compliance, quality, and inspection readiness in an increasingly AI-driven regulatory landscape.

Not sure where your organization stands today?

PharmaRelations helps Life Science companies establish practical AI governance frameworks, assess compliance risks, and integrate AI into quality systems in line with evolving regulatory expectations.

Contact our QA experts to discuss your AI governance strategy:

Kent Wiberg
Nordic Head of Quality Assurance
+46 70 165 22 96 | kent.wiberg@pharmarelations.se

Hossein Asgari
Head of Quality Assurance, Denmark
+45 54 33 01 39 | hossein.asgari@pharmarelations.dk

 Get in touch to explore how AI can be leveraged compliantly within your GxP environment.